Correlation of F-18-FDG PET/CT Findings With Histopathological Results in Differentiated Thyroid Cancer Patients Who Have Increased Thyroglobulin or Antithyroglobulin Antibody Levels and Negative I-131 Whole-Body Scan Results

ÖZKAN E., Aras G., KÜÇÜK N. Ö.

CLINICAL NUCLEAR MEDICINE, cilt.38, sa.5, ss.326-331, 2013 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 38 Sayı: 5
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1097/rlu.0b013e318286827b
  • Dergi Adı: CLINICAL NUCLEAR MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.326-331
  • Anahtar Kelimeler: differentiated thyroid cancer, F-18-FDG, PET/CT, thyroglobulin, antithyroglobuline antibody, EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY, ELEVATED THYROGLOBULIN, SERUM THYROGLOBULIN, DIAGNOSTIC-ACCURACY, FOLLOW-UP, CARCINOMA, RECURRENCE, PAPILLARY, IMPACT
  • Ankara Üniversitesi Adresli: Evet

Özet

Aim: This study aimed to investigate the correlation of F-18-FDG PET/CT findings with histopathological results in defining the recurrence of the disease in patients with differentiated thyroid cancer (DTC) who have increased thyroglobuline (Tg) or anti-Tg antibody (TgAb) levels and negative I-131 whole-body scan (WBS) result.